Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, July 1998, p. 1689-1694, Vol. 42, No. 7
Centre de Recherche en Infectiologie du CHUL
and Département de Biologie Médicale, Division de
Microbiologie, Université Laval, Québec, Canada
Received 17 February 1998/Returned for modification 17 March
1998/Accepted 5 May 1998
Leishmania tarentolae promastigotes were selected step
by step for resistance to sodium stibogluconate (Pentostam). Mutants resistant to antimony-containing drugs and cross-resistant to arsenite
were therefore obtained. Amplification of one common locus was observed
in several independent sodium stibogluconate-resistant mutants, and the
locus amplified was novel. The copy number of the amplified locus was
related to the level of resistance to pentavalent antimony. The gene
responsible for antimony resistance was isolated by transfection and
was shown to correspond to an open reading frame coding for 770 amino
acids. The putative gene product did not exhibit significant homology
with sequences present in data banks, and the putative role of this
protein in antimony resistance is discussed.
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Gene Amplification in Leishmania
tarentolae Selected for Resistance to Sodium
Stibogluconate
*
Corresponding author. Mailing address: Centre de
Recherche en Infectiologie, 2705, boul. Laurier, Sainte-Foy,
Québec G1V 4G2, Canada. Phone: (418) 654-2705. Fax: (418)
654-2715. E-mail: Marc.Ouellette{at}crchul.ulaval.ca.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |